and 2.98 nM for prothrombinase.128 Edoxaban exhibits linear pharmacokinetics and produces concentration-dependent increases in the PT,INR, and aPTT.However,changes in these laboratory assays with edoxaban tend to be unpredictable and highly variable, reducing their use as a monitoring tool in clinical...
edoxaban外文综述 以下是关于 edoxaban 的英文综述：Edoxaban is an oral anticoagulant medication that belongs to the class of direct oral anticoagulants (DOACs). It is used to prevent and treat blood clots in patients with atrial fibrillation, deep vein thrombosis, or pulmonary embolism.Edoxaban works ...
Edoxaban is a direct activated factor X inhibitor with attractive features among which are once daily dosing, no need for routine monitoring, and minimal drug-drug interactions. In patients undergoing orthopedic surgery, edoxaban was superior to enoxaparin in preventing VTE. Furthermore, a recent ...
we are trying to provide high-quality product with low-cost, paying attention to reach a satisfied result as well. In the field of pharmaceutical research, time means everything, we will also keep monitoring the process of the compound from the beginning of synthesis to the delivery, endeavor...
If your doctor has directed you to use this medication, your doctor or pharmacist may already be aware of any possible drug interactions and may be monitoring you for them. Do not start, stop, or change the dosage of any medicine before checking with your doctor, health care provider or ph...
Anticoagulant Monitoring/ BIOPHEN™ Edoxaban Control BIOPHEN™ Edoxaban Control Code: A225501-RUOManufacturer’s Part Number: 225501-RUOProduct size: 2 x 6 x 1 mLClearance: RUOPrice: $324.00 Qty Add to Cart Product Description In US and Canada: For Research Use Only. Not for Use in Diag...
2.98 nM for prothrombinase.128 Edoxaban exhibits linear pharmacokinetics and produces concentration-dependent increases in the PT,INR, and aPTT.However,changes in these laboratory assays with edoxaban tend to be unpredictable and highly variable, reducing their use as a monitoring tool in clinical ...
In the field of pharmaceutical research, time means everything, we will also keep monitoring the process of the compound from the beginning of synthesis to the delivery, endeavoring meeting our clients’ expectation. 进入公司首页> 成立时间: 2015-03-30 企业经济性质: 私营独资企业 年营业额...
Historically, vitamin K antagonists have been the only class of oral anticoagulants available. Despite our experience with warfarin over the past 60 years, its use is associated with several pharmacokinetic and clinical disadvantages including unpredictable dosing, frequent monitoring, and delayed onset and...
Edoxaban, an oral direct factor Xa inhibitor, does not require routine monitoring. However, assessment of the anticoagulant effects may be required in cert... Yoshiyuki,Morishima,Chikako,... - 《American Journal of Clinical Pathology》 被引量: 51发表: 2015年 ...